RxDoctor Payments Data

Melanie White

Family · Knightdale, NCNPI 1144655333

Payments from drug & device makers

$1,966in general payments, 2019–2025

Across 110 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Otsuka America Pharmaceutical, Inc.$144
  • Abbott$120
  • Boehringer Ingelheim$85
  • AbbVie$81
  • AstraZeneca$75
  • plus $450 from 15 others

What the payments were for

  • Food & beverage$1,966100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,966 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$37,527
Medicare patients
125
Services billed
502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$91,540
JardianceEmpagliflozin25$32,472
RybelsusSemaglutide19$23,349
EliquisApixaban21$23,215
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$9,244
MyrbetriqMirabegron16$7,969
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$6,884
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$4,719
Atorvastatin Calcium196$2,578
Albuterol Sulfate HfaAlbuterol Sulfate65$2,093
Humalog Kwikpen U-100Insulin Lispro11$1,737
Gabapentin118$1,692
Losartan Potassium138$1,600
Omeprazole126$1,489
Bupropion XlBupropion Hcl40$1,318

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,010$114,88985 claims
Boehringer IngelheimJardiance$85$32,47225 claims
PfizerEliquis$13$23,21521 claims
GSKTrelegy Ellipta$13$9,24412 claims
AbbVieSynthroid$81$88119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,522 family providers in North Carolina.

Other family in Knightdale

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →